Trial reportBMC complementary medicine and therapies2025
Effects of auriculotherapy on urinary incontinence in men with prostate cancer: a randomized controlled trial.
Trial report in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundUrinary incontinence is one of the most distressing common symptoms in patients with prostate cancer after surgery. Auriculotherapy has been shown to improve a variety of symptoms effectively and has a certain potential in managing urinary incontinence, but the relevant studies are few and inconclusive. This study aimed to assess the effectiveness of auriculotherapy on urinary incontinence in men with prostate cancer.
methodsParticipants were recruited from the urology ward of a tertiary hospital between October 2023 and April 2024. A total of 114 men who underwent radical prostatectomy were randomly assigned to the usual care (n = 38), sham-auriculotherapy (n = 38), or true-auriculotherapy (n = 38) groups. All groups received pelvic floor muscle training, and the intervention groups received four additional sham-auriculotherapy or true-auriculotherapy. The primary outcomes were the International Advisory Committee on Urinary Incontinence Questionnaire short form (ICIQSF) score and clinical effective rate, the secondary outcomes included the continence rate, pad usage, urinary incontinence severity, urinary incontinence episodes, and quality of life. Data were collected at week 2, week 4, week 8, and week 12 after surgery. Generalized estimating equations were applied for outcome comparison.
resultsThe true-auriculotherapy group had significantly lower ICIQSF scores (β = -1.93, 95% CI: -3.21, -0.65, P = 0.030), higher clinical effective rates (OR = 1.12, 95% CI: 1.04, 1.20, P = 0.003), lower pad uses (β = -0.50, 95% CI: -0.93, -0.07, P = 0.023), and higher Incontinence Quality of Life Instrument scores (β = 3.82, 95% CI: 1.55, 6.09, P = 0.001) than usual care group, while no significant difference was noted between the sham-auriculotherapy and usual care groups. The continence rates were not significantly different among the three groups. In terms of the simplified version of the Expanded Prostate Cancer Review Index, the true-auriculotherapy exhibited greater improvements in the "urinary incontinence", "urinary irritation /obstruction", and "hormonal" domains than usual care at week 12, but showed no significant differences regarding "bowel" and "sexual" domains. The sham-auriculotherapy was superior to usual care only in the "hormonal" domain and was not significantly different in the other domains.
conclusionAuriculotherapy is a relatively simple, low-cost, low-risk, and effective nonpharmacological approach for alleviating urinary incontinence. Regular and consistent acupressure is essential to maintain the effectiveness of auriculotherapy. The long-term effectiveness and mechanism of auriculotherapy need to be further explored.
trial registrationChiCTR2300071700, available on the Chinese Clinical Trial Registry ( www.chictr.org.cn ). The first registration date was 23/05/2023.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.